Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. BE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. ROIV

Go back to Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies
Gilead Sciences (NASDAQ: GILD) Delayed: 151.00 +0.01 (0.01%)
Previous Close $150.99    52 Week High $108.63 
Open $151.00    52 Week Low $71.39 
Day High $151.00    P/E 83.43 
Day Low $151.00    EPS $1.81 
Volume 3,012